Y. Tsujita et al., Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: The Suita Study, HYPERTENS R, 24(2), 2001, pp. 105-109
Aldosterone synthase(CYP11B2) is a key enzyme in the biosynthesis of aldost
erone. Recently, a polymorphism in the 5'-flanking region of the CYP11B2 ge
ne CT(-344)C] has been reported to be associated with blood pressure and pl
asma aldosterone levels. We investigated the association between this polym
orphism and hypertension in a large population-based sample of 4,000 Japane
se, The genotype distribution in hypertensive subjects (n=1,535) was compar
ed to that in normotensive subjects (n=2,514), In subjects not receiving an
tihypertensive medication, the influence of the genotype on blood pressure
values adjusted for clinical covariates was analyzed. All analyses were per
formed separately for men and women. The genotype distribution did not diff
er between hypertensive and normotensive subjects in either men (frequency
of C allele: 30.3% vs, 31.4%, p=0.48) or women (31.5% vs. 31.7%, p=0.93). T
here were no significant differences in systolic blood pressure, diastolic
blood pressure, or pulse pressure among the three genotypes in either men o
r women who had not received hypertensive medication. Our data suggest that
the T(-344)C polymorphism of CYP11B2 is unlikely to influence blood pressu
re status in the Japanese population.